TUESDAY, July 19, 2022 (HealthDay News) — The nation’s opioid epidemic is hitting minority groups the hardest, with the latest government study reporting the steepest increases in overdose deaths among Black Americans and American Indians/Alaska Natives. While overdose deaths climbed 24% among whites in 2020, still an historic high, theyContinue Reading
FRIDAY, July 15, 2022 (HealthDay News) — With monkeypox cases continuing to climb in the United States, federal health officials said Friday they have ordered another 2.5 million doses of monkeypox vaccine and boosted national testing capacity to respond to the outbreak. The news comes not a moment too soon,Continue Reading
FRIDAY, July 15, 2022 (HealthDay News) — Roughly 25 million children around the world missed critical vaccinations during 2021, as the pandemic continued to disrupt routine medical care, a new report from the World Health Organization and UNICEF shows. “This is a red alert for child health. We are witnessingContinue Reading
FRIDAY, July 15, 2022 (HealthDay News) — People shouldn’t take the drugs colchicine and fluvoxamine to treat mild to moderate COVID-19, the World Health Organization (WHO) is warning. The antidepressant drug fluvoxamine (Luvox) and the gout drug colchicine are commonly used and inexpensive drugs that have received considerable interest asContinue Reading
FRIDAY, July 15, 2022 (HealthDay News) — An off-brand medication for diabetic macular edema might prove just as effective in early treatment as its more expensive alternative, potentially saving patients thousands of dollars, new research suggests. The vision condition is a common complication of poorly controlled diabetes, which can damageContinue Reading
THURSDAY, July, 14, 2022 (HealthDay News) — As monkeypox cases continue to climb worldwide, demands for vaccines to combat the virus are crashing the vaccine appointment system in New York City. The city of over 8 million people has been running out of supplies almost as soon as they arrive,Continue Reading
THURSDAY, July 14, 2022 (HealthDay News) — A drug used “off-label” for multiple sclerosis (MS) is more effective than a standard medication at preventing symptom flare-ups, a new clinical trial has found. The drug, called rituximab, is approved in the United States for treating certain cancers and autoimmune diseases. ItContinue Reading
THURSDAY, July 14, 2022 (HealthDay News) – Unvaccinated Americans should soon have a fourth COVID vaccine option. On Wednesday, Novavax’s offering was the latest to receive emergency use approval from the U.S. Food and Drug Administration. Advisors to the U.S. Centers for Disease Control and Prevention will meet next weekContinue Reading
THURSDAY, July 14, 2022 (HealthDay News) — Giving more patients at-home access to the opioid addiction treatment drug methadone during the COVID pandemic did not lead to more overdose deaths, a nationwide study shows. The research, which covered the period from January 2019 to August 2021, found that the pushContinue Reading
WEDNESDAY, July 13, 2022 (HealthDay News) — People with lupus benefit from a COVID-19 booster shot after full vaccination, with a new study showing they are half as likely to experience a COVID infection afterward. “Our study results offer people living with systemic lupus erythematosus (SLE) clinical confirmation that vaccinesContinue Reading